The introduction of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable interest within the medical community. This groundbreaking dual GIP and GLP-1 agonist medication seems to provide significant improvements in fat reduction compared to existing therapies. Early patient data have … Read More